Redundant Publication

AUTHOR: J.D. ANDRADE, p.12 I enjoyed the article "Vigilant Science Journal Editors Fight Redundancy" (Paul McCarthy, The Scientist, March 8, 1993, page 1). The real incentive for literature pollution, or your more polite term "literature redundancy," is the evaluation and reward system at most universities. Administrators and colleagues still decide tenure and promotion cases largely on the basis of numbers of papers in "peer- reviewed" journals. There rarely is any consideration of the signi

Written byJ Andrade
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

AUTHOR: J.D. ANDRADE, p.12

I enjoyed the article "Vigilant Science Journal Editors Fight Redundancy" (Paul McCarthy, The Scientist, March 8, 1993, page 1).

The real incentive for literature pollution, or your more polite term "literature redundancy," is the evaluation and reward system at most universities.

Administrators and colleagues still decide tenure and promotion cases largely on the basis of numbers of papers in "peer- reviewed" journals. There rarely is any consideration of the significance, the citation impact, or the redundancy of those papers. If we simply asked all retention, promotion, and tenure evaluators to consider redundancy as a negative factor in the algorithm, the problem would rapidly disappear.

There should also be an incentive for members of the community to call on the carpet colleagues who are guilty of publishing redundant papers. Perhaps newspapers like The Scientist could provide some PR and notoriety by, for example, selecting the "most redundant ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies